New Horizons in Equine Joint Care with Injectable Polyacrylamide Hydrogel

Send us a text

Discover groundbreaking insights as we chat with Dr. Jason Lowe about innovative research on equine joint health, recently spotlighted in JAVMA. Prepare to have your perspectives shifted on the veterinary approach to joint disease, inflammation, and immune responses, as Jason unveils the results of a study on 2.5% injectable polyacrylamide hydrogel. The study findings reveal an intriguing, macrophage-driven inflammatory response that is transient and stays within normal lab ranges, resolving within 90 days. We explore how this treatment remarkably becomes one with the joint, encouraging the formation of a new synovial cell layer, and we consider the implications for equine sports medicine.

Our conversation doesn't stop at the cellular level; we also tackle the practicalities of equine joint management. Emphasizing the critical role of accurate diagnosis prior to intervention, we discuss how a deep understanding of polyacrylamide hydrogel can dramatically enhance joint function and how adopting a proactive treatment strategy can boost the performance and longevity of equine athletes.

Open access article: https://doi.org/10.2460/javma.23.10.0553

INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ?

JAVMA ® : https://avma.org/JAVMAAuthors

AJVR ® : https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA ® :

Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook

Instagram: JAVMA (@avma_javma) • Instagram photos and videos

Twitter: JAVMA (@AVMAJAVMA) / Twitter

AJVR ® :

Facebook: American Journal of Veterinary Research - AJVR | Facebook

Instagram: AJVR (@ajvroa) • Instagram photos and videos

Twitter: AJVR (@AJVROA) / Twitter

JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals